Ledger.Open graph →
SEC Form D · Amendment · filed January 27, 2021

Phylos Bioscience, Inc

Offering
$25.0M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Ralph J. Risch · Portland, ORExec · DirectorScott J. Bowman · Portland, ORExecTimothy J. Gregory · Portland, ORDirectorNishan Karassik · Portland, ORExec · DirectorDavid J. Patterson · Portland, ORDirectorDaniella Kranjac · Englewood Cliffs, NJDirectorNell M. Blatherwick · CHICAGO, ILExecMichael D. Feinglass · CHICAGO, ILExec · DirectorDavid M. Mccoy · CHICAGO, ILExec · DirectorSilvio Marra, Md · Tinley Park, ILDirectorStanton T. Marcum · Sanibel, FLExec · DirectorAndrea T. Johnson · Florence, KYExec · DirectorVehano Joseph · Tampa, FLExecMatthew Morgan · Boston, MADirectorRichard J. Foust · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗